These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32084290)

  • 1. The cost of dupilumab treatment for severe atopic dermatitis is largely offset by broader health-care savings and improvement in quality of life.
    Edwards HA; McMeniman EK
    Australas J Dermatol; 2020 May; 61(2):e273-e275. PubMed ID: 32084290
    [No Abstract]   [Full Text] [Related]  

  • 2. A critical appraisal and implications of the new National Institute for Health and Care Excellence guideline on dupilumab for treating moderate-to-severe atopic eczema.
    Weidinger S; Apfelbacher C
    Br J Dermatol; 2019 Mar; 180(3):435-437. PubMed ID: 30821391
    [No Abstract]   [Full Text] [Related]  

  • 3. Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States.
    Khosravi H; Zhang S; Anderson AM; Ferris LK; Choudhary S; Patton T
    J Am Acad Dermatol; 2020 Apr; 82(4):1023-1024. PubMed ID: 31866263
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
    Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
    J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
    Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
    J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
    [No Abstract]   [Full Text] [Related]  

  • 6. Italian healthcare resource consumptions and direct costs of adults with atopic dermatitis before and after dupilumab treatment.
    Ronconi G; Dondi L; Calabria S; Dondi L; Pedrini A; Esposito I; Scattareggia M; Rogliani P; Trimarchi M; Costanzo A; Patruno C; Naldi L; Martini N
    Ital J Dermatol Venerol; 2024 Aug; 159(4):417-424. PubMed ID: 39069839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
    Paller AS; Bansal A; Simpson EL; Boguniewicz M; Blauvelt A; Siegfried EC; Guttman-Yassky E; Hultsch T; Chen Z; Mina-Osorio P; Lu Y; Rossi AB; He X; Kamal M; Graham NMH; Pirozzi G; Ruddy M; Eckert L; Gadkari A
    Am J Clin Dermatol; 2020 Feb; 21(1):119-131. PubMed ID: 31823222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
    Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A
    Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Johansson E, Giovannitti M, Mezzetti M, et al. Cost-effectiveness analysis of baricitinib versus dupilumab for moderate to severe atopic dermatitis: an Italian healthcare system perspective. J Med Econ. 2023;26(1):1155-1166.
    Pedone MP; Dobreva M; Bastian M; Tavi J; Noonan K
    J Med Econ; 2024; 27(1):800-802. PubMed ID: 38842021
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow-up.
    Romagnuolo M; Angileri L; Tavecchio S; Marzano AV; Ferrucci S
    Clin Exp Dermatol; 2020 Aug; 45(6):762-763. PubMed ID: 32379943
    [No Abstract]   [Full Text] [Related]  

  • 11. A life with atopic dermatitis: the patient's point of view after a new hope with dupilumab.
    D'Adamio S; Massaro A; Biocca S; Bianchi L; Talamonti M; Galluzzo M
    Clin Exp Dermatol; 2020 Aug; 45(6):809-810. PubMed ID: 32472943
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycosis Fungoides Unmasked by Dupilumab Treatment in a Patient With a History of Atopic Dermatitis.
    Ayasse M; Nelson K; Glass F; Silverberg JI
    Dermatitis; 2021 Oct; 32(1S):e88-e89. PubMed ID: 33273230
    [No Abstract]   [Full Text] [Related]  

  • 13. Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome.
    Sogkas G; Hirsch S; Jablonka A; Witte T; Schmidt RE; Atschekzei F
    Clin Immunol; 2020 Jun; 215():108452. PubMed ID: 32360519
    [No Abstract]   [Full Text] [Related]  

  • 14. Dupilumab for treatment of severe atopic dermatitis in a heart transplant recipient.
    Hamid RN; Bomar L; Strowd L
    Cutis; 2019 Jun; 103(6):E1-E2. PubMed ID: 31348459
    [No Abstract]   [Full Text] [Related]  

  • 15. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
    Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
    BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EFFECTS OF DUPILUMAB ON PERENNIAL ALLERGIC RHINITIS IN ATOPIC DERMATITIS PATIENTS].
    Yamamoto M; Okuno M; Sasaki T; Fujimoto R; Kataoka Y; Kawashima K
    Arerugi; 2020; 69(10):979-988. PubMed ID: 33310981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real-life practice.
    Tauber M; Apoil PA; Richet C; Laurent J; De Bonnecaze G; Mouchon E; Cassagne M; Marguery MC; Hegazy S; Konstantinou MP; Severino M; Uthurriague C; Giordano-Labadie F; Didier A; Paul C
    Br J Dermatol; 2019 Jun; 180(6):1551-1552. PubMed ID: 30633329
    [No Abstract]   [Full Text] [Related]  

  • 18. [Psoriasis in dupilumab-treated atopic dermatitis].
    Senner S; Eicher L; Aszodi N; Prinz JC; French LE; Wollenberg A
    Hautarzt; 2020 May; 71(5):383-386. PubMed ID: 32179945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for Successful Management of Severe Atopic Dermatitis.
    Brar KK; Nicol NH; Boguniewicz M
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):1-16. PubMed ID: 30598172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of atopic keratoconjunctivitis during treatment with dupilumab for atopic dermatitis.
    Cheng J; Jiang L; Morrow NC; Avdic A; Fairley JA; Ling JJ; Greiner MA
    J Am Acad Dermatol; 2021 Jul; 85(1):265-267. PubMed ID: 32956738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.